4.4 Article

A case of Werner syndrome without metabolic abnormality: Implications for the early pathophysiology

Journal

GERIATRICS & GERONTOLOGY INTERNATIONAL
Volume 12, Issue 1, Pages 140-146

Publisher

WILEY-BLACKWELL
DOI: 10.1111/j.1447-0594.2011.00743.x

Keywords

early diagnosis; insulin resistance; mutation; tendinous calcinosis; Werner syndrome

Funding

  1. Ministry of Education, Culture, Sports, Science and Technology
  2. Ministry of Health, Labor and Welfare
  3. Fujii Setsuro Memorial Osaka Basic Research Foundation
  4. Grants-in-Aid for Scientific Research [24659346] Funding Source: KAKEN

Ask authors/readers for more resources

Werner syndrome (WS) is an autosomal recessive progeroid disorder caused by mutations in the WRN DNA helicase. It is characterized by the graying and loss of hair, juvenile cataracts, sclerosis and ulceration of skin, insulin-resistant diabetes mellitus, dyslipidemia, abdominal adiposity, osteoporosis, atherosclerosis, and malignant neoplasm. Patients are usually diagnosed in their 30s or 40s, but the early pathophysiology of the syndrome is still not fully understood. Here we report a 29-year-old female patient who displayed cataracts, hair graying, and tendinous calcinosis. Her parents were first cousins. Interestingly, the patient lacked the metabolic signs typical for WS, including glucose intolerance, dyslipidemia, and visceral fat accumulation. A hyperinsulinemic response at 30 min was observed in an oral glucose tolerance test. Mutational analysis for the WRN gene revealed a homozygous nucleotide substitution 3190C>T in exon 24, resulting in a protein product with replacement of an arginine residue at position 573 by termination codon (Arg987Ter). The mutated WRN protein was unable to translocate into the nucleus in an in vitro cell assay. A WS patient with an Arg987Ter mutation has been previously reported in Switzerland, the present case is the first to be identified in Asia. This case demonstrates the early clinical features of WS and suggests that metabolic abnormality, including insulin resistance, is not an essential component of WS at disease onset. Moreover, a follow-up study of such case would be useful to understand how the various clinical symptoms in WS develop and progress over the years. Geriatr Gerontol Int 2012; 12: 140146.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available